San Diego biotech se­cures $75M to ad­vance lead can­di­date

Arthrosi Ther­a­peu­tics, a biotech com­pa­ny de­vel­op­ing a gout treat­ment, raised a fresh $75 mil­lion through a Se­ries D round.

Ac­cord­ing to a press re­lease on Tues­day, Guan­grun Health In­dus­try led the round along­side oth­er in­vestors, in­clud­ing Re­ich­stein Biotech, a sub­sidiary of Api­cHope Phar­ma­ceu­ti­cals. Arthrosi hasn’t shared news about pre­vi­ous fi­nanc­ing rounds, but da­ta from Pitch­Book show that this was the sev­enth round. It last raised $15 mil­lion in March and has raised a to­tal of $154.1 mil­lion, ac­cord­ing to Pitch­Book.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER